Jeremy D. Sanderson

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors

M. Parkes, J. Sanderson, J. Reynolds, 2017, Alimentary pharmacology & therapeutics.